from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2108/PPE36

LFCtreatmentdescriptionclass of inhibitor

0.132

Amikacinug/mL Amikacintranslation

0.464

Cap5-10ug/mL Capreomycintranslation

1.263

Rox10-50 ug/mL Roxithromycintranslation

0.988

SM2-5 ug/mL Streptomycintranslation

0.842

Tet5-10 ug/mL Tetracyclinetranslation

0.338

Rif0.2-5ug/mL Rifampicintranscription

0.277

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.210

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.523

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.815

CPZ10-50 ug/mL Chlorpromazinerespiration

1.047

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.034

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.058

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.236

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.324

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.148

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.421

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.741

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.043

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.257

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

2.221

Nigericin50 uM Nigericinrespiration

-0.053

TRC10-150 ug/mL Triclosanrespiration

-0.679

TRZ10-25 ug/mL Thioridazinerespiration

1.413

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.777

menadione6-10 ug/mL Menadionerespiration

0.545

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.886

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.206

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.220

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.265

NRP_1Non-replicating persistence stage 1dosRassociated

-0.310

Amp0.2mg/mL AmpicillincellWall

-0.061

Cephalexin20-100 ug/mL CephalexincellWall

0.559

Cerulenin0.32-5 ug/mL CerulenincellWall

0.051

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.460

EMB10-20 ug/mL EthambutolcellWall

1.677

Eta12-40 ug/mL EthionamidecellWall

0.158

INH0.2-0.4 ug/mL IsoniazidcellWall

0.317

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.123

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.715

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.362

BZA0.12 mg/mL BenzamidearomaticAmides

-0.386

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.611

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.549

H2O24 mM hydrogen peroxideDNAdamaging

-0.266

Levo10 ug/mL LevofloxacinDNAdamaging

0.388

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.779

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.152

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.416

UVUV-irradiationDNAdamaging

-1.147

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.526

Antimycin12.5-50 ug/mL Antimycin A?

-0.370

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.216

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.053

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.821

PA8240.2-2 ug/mL PA-824?

0.278

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.504

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.241

Verapamil50 uM Verapamil?

-0.281

mercaptoethanol2 mM 2-Mercaptoethanol?

0.402

methoxatin10-20 ug/mL Methoxatin?